Geneva Partners, LLC Agilent Technologies, Inc. Transaction History

Geneva Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$147.95 - $164.3 $357,299 - $396,784	-2,415 Closed	0 $0
Q3 2021 Oct 18, 2021	BUY	$147.58 - $179.28 $122,491 - $148,802	830 Added 52.37%	2,415 $380,000
Q2 2021 Aug 06, 2021	BUY	$127.69 - $148.81 $202,388 - $235,863	1,585 New	1,585 $234,000
Q2 2018 Aug 09, 2018	SELL	$61.14 - $69.55 $254,036 - $288,980	-4,155 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$65.05 - $74.82 $116,114 - $133,553	-1,785 Reduced 30.05%	4,155 $278,000
Q4 2017 Feb 08, 2018	SELL	$64.87 - $70.59 $129,740 - $141,180	-2,000 Reduced 25.19%	5,940 $398,000
Q3 2017 Nov 08, 2017	BUY	$58.57 - $66.17 $465,045 - $525,389	7,940	7,940 $510,000

1,112

260M

1.11M

970K

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $42.9B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Partners, LLC with notifications on news.